Max Nisen is a Bloomberg Gadfly columnist covering biotech, pharma and health care. He previously wrote about management and corporate strategy for Quartz and Business Insider.

Good morning! This is Fly Charts, the daily charts-only newsletter from Gadfly; sign up here. From the morality of VC investing to Samsung's breakneck growth, here are four charts that tell you what you need to know in business today.

Let's Make a Deal
Berkshire has too much cash and few appealing ways to spend it. A $9 billion purchase of Oncor would barely make a dent.
Source: Bloomberg
All Alone
Venture capital returns surpass the broader market, but socially responsible investors need to consider whether that's worth it, given Silicon Valley's array of ethical issues.
Sources: Cambridge Associates, S&P, MSCI
Spoiled Food
Campbell has struggled with non-soup ventures -- including a $147 million carrot-related writedown -- so it's doubling down on what it knows best.
Source: Bloomberg
Justified Confidence
Samsung's operating profit and share price have both soared, but investors now have to decide whether it can repeat the feat.
Source: Bloomberg

And don't miss Lionel Laurent on Brits blaming the EU for trouble at RBS: "This kind of thinking is wrong-headed on several levels. It ignores the state of the seller, for one thing. RBS had been run into the ground through empire-building and reckless risk-taking. A failure was averted only by a colossal taxpayer injection of 45 billion pounds. Since then, RBS has posted nine straight years of losses, totaling 58 billion pounds. The bank is half the size it was in 2008. Worldpay is only one of many assets the lender had to sell to stem its losses and stand a remote chance of paying back the taxpayer."

This column does not necessarily reflect the opinion of Bloomberg LP and its owners.

To contact the author of this story:
Max Nisen in New York at

To contact the editor responsible for this story:
Mark Gongloff at